All Posts

ViVerita Therapeutics today announced a strategic research collaboration with Boehringer Ingelheim aimed at accelerating the discovery...

Exciting news! Nature Reviews Cancer and Christopher Lowden published a very insightful article on the power of CRISPR-StAR to transform...

Nature Methods highlights CRISPR-StAR, the proprietary CRISPR-screening technology of ViVerita. https://www.nature.com/articles/s41592-02...

ViVerita announces to having executed a licensing deal for CRISPR-StAR and CRISPR-Switch, two proprietary technologies developed by...

The proprietary technology to empower high resolution in vivo CRISPR screening was published in Nature biotechnology. This method,...